Insights into Clinical Features and Outcomes of Adrenal Cortical Carcinosarcoma
Open Access
- 6 October 2022
- journal article
- case report
- Published by MDPI AG in Diagnostics
- Vol. 12 (10) , 2419
Abstract
Adrenal cortical carcinosarcomas are a rare and typically aggressive malignancy with few reported cases in medical literature. We present a case of a 78-year-old female who presented with complaints of fatigue and right shoulder pain. Imaging of the abdomen with computed tomography visualized a large mass in the right upper quadrant. The mass was radiologically described as a 22 × 17 × 13 cm heterogeneous mass with its epicenter in the area of the right adrenal gland, with medial and peripheral effacement of all structures in the right upper quadrant. Non-contrasted images demonstrated anterior mid-portion calcifications. The mass parasitized its blood supply from several surrounding structures, including the liver and right psoas muscle, and extensively invaded the psoas muscle. Resection of the mass was performed with pathology, which revealed a high mitotic index and nuclear atypia with two morphologically and immunophenotypically distinct components. One of these components stained positively for calretinin and inhibin, which is indicative of adrenal cortical carcinoma; the other exhibited strong expression of vimentin and desmin, which was concordant with sarcomatous change and confirmed the diagnosis of adrenal cortical carcinosarcoma. This unique histology with both carcinomatous and sarcomatous components presents a diagnostic challenge for clinicians. As such, adrenal carcinosarcomas should be kept on the differential when evaluating retroperitoneal masses. Additionally, this study includes a review of 34 previously reported cases of adrenal cortical carcinosarcomas along with a discussion about the future exploration of this pathology.Keywords
This publication has 46 references indexed in Scilit:
- Primary adrenocortical sarcomatoid carcinoma: Report of a caseCanadian Urological Association Journal, 2012
- Therapeutic Management of Advanced Adrenocortical Carcinoma: What Do We Know in 2011?Discover Oncology, 2011
- Adrenal sarcomatoid carcinoma: A rare case depicted on multi-detector row computed tomographyIndian Journal of Medical Sciences, 2010
- Adjuvant Therapy With the Monoclonal Antibody Edrecolomab Plus Fluorouracil-Based Therapy Does Not Improve Overall Survival of Patients With Stage III Colon CancerJournal of Clinical Oncology, 2009
- Overexpression of epithelial cell adhesion molecule (Ep-CAM) is an independent prognostic marker for reduced survival of patients with epithelial ovarian cancerGynecologic Oncology, 2006
- The carcinoma-associated antigen EpCAM upregulates c-myc and induces cell proliferationOncogene, 2004
- Ep-CAM: a human epithelial antigen is a homophilic cell-cell adhesion molecule.Journal of Cell Biology, 1994
- Carcinosarcoma of the Adrenal Cortex Presenting with Mineralocorticoid ExcessAmerican Journal of Surgical Pathology, 1993
- Adrenal Carcinosarcoma Presenting in a Woman With Clinical Signs of Virilization A Case Report With Immunohistochemical and Ultrastructural FindingsAmerican Journal of Surgical Pathology, 1992
- Adrenal carcinosarcomaJournal of Surgical Oncology, 1990